NASDAQ
Esperion Therapeutics, Inc. (ESPR) has a fcf yield of -1.70% as of Friday, May 29, 2026. This represents a 97.52% increase compared to its 12-month average of -68.64%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.